July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
July 24, 2024 — Increasing ketone supply to the heart in mice with heart failure with preserved ejection fraction (HFpEF ...
Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and ...
July 23, 2024 — The Society of Cardiovascular Computed Tomography (SCCT) announced its best original science award ...
July 23, 2024 — The International Atherosclerosis Society (IAS) has released a clinical proceedings white paper ...
July 19, 2024 — The Society of Cardiovascular Computed Tomography (SCCT) received near-record breaking submissions of ...
July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...
July 18, 2024 — AliveCor, a global leader in AI-powered cardiology, today announced that the American Medical ...
On July 16, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows ...
July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...
July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...
July 11, 2024 — Dr. Fadi Mansour performed the first Canadian implant of BIOTRONIK’s newest pacemaker and CRT-P ...
July 11, 2024 — Heart Test Laboratories, Inc. an artificial intelligence (AI)-powered medical technology company focused ...
July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...
July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...